• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT ANTI-HBS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT ANTI-HBS Back to Search Results
Catalog Number 07C18-29
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/05/2019
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.There was no additional patient information provided.This report is being filed on an international product, list number 7c18 that has a similar product distributed in the us, list number 1l82.
 
Event Description
The customer reported (b)(6) architect anti-hbs results on one patient.The results provided were: (b)(6) 2013 = (b)(6) / (b)(6) 2019 = (b)(6) / (b)(6) 2019 = (b)(6) / (b)(6) 2019 = (b)(6) / (b)(6) 2019 = (b)(6) / (b)(6) 2019 = (b)(6).There was no reported impact to patient management.
 
Manufacturer Narrative
A review of tickets found only one additional ticket for false reactive anti-hbs results for lot 01345fn00.A review of the trending report determined that there are no trends for the issue for the lot.Return testing was not completed as returns were not available.Historical performance in the field of architect anti-hbs reagent lots using world wide data through abbottlink was evaluated.The patient median result for lot 01345fn00 was comparable with all other lots in the field and confirms no systemic issue for the lot.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.Labeling was reviewed which adequately addresses the current issue.The product labeling states that for diagnostic purposes, results should be used in conjunction with patient history and other hepatitis markers for diagnosis of acute, chronic, or recovered infection.It is possible that the potential falsely elevated results are due to reactivity following transfusion.Based on the investigation no product deficiency was identified for the architect anti-hbs reagent, lot 01345fn00.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT ANTI-HBS
Type of Device
ANTI-HBS
Manufacturer (Section D)
ABBOTT IRELAND
diagnostics division
finisklin business park
sligo NA
EI  NA
MDR Report Key8838064
MDR Text Key160374529
Report Number3008344661-2019-00093
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 10/14/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/14/2020
Device Catalogue Number07C18-29
Device Lot Number01345FN00
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/09/2019
Initial Date FDA Received07/29/2019
Supplement Dates Manufacturer Received10/07/2019
Supplement Dates FDA Received10/14/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000 ANALYZER, LN 08C89-01,; ARCHITECT I2000 ANALYZER, LN 08C89-01,; SERIAL # (B)(4); SERIAL # (B)(4)
Patient Age82 YR
-
-